4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001144204-18-033605
Options or other derivatives
- CEO and President acquired 603,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KLEMP WALTER V CEO and President | 2018-06-06 | Grant or award · Stock option (right to buy) | +603,000 | 943,000 | D: show line 1 in the form |
Loading xslF345X03/tv496089_4.xml…